The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.

If the FeNO level is not raised, it is recommended that the patient be offered either a Long-Acting Muscarinic Antagonist ...

The Asthma and Allergy Foundation of America ranks Dallas 13th among the top 100 most challenging places to live with seasonal allergies. That can be challenging for children with asthma. KERA’s Sam ...

Medically reviewed by Daniel More, MD People with allergic asthma experience asthma symptoms and attacks when exposed to pollen, dust, or pet dander. Though no food can cure or treat asthma, ...

Asthma continues to be a major global health issue, affecting over 330 million people and causing around 250,000 deaths each year-roughly 1,000 deaths daily. Asthma is caused by inflammation in the ...